Talphera Inc stock is traded at $0.906, with a volume of 1,219,599. It is down -12.46% in the last 24 hours and down -15.33% over the past month. Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Previous Close:
$1.04
Open:
$0.9898
24h Volume:
1,219,599
Relative Volume:
5.01
Market Cap:
$47.03M
Revenue:
$1,000
Net Income/Loss:
-$14.25M
P/E Ratio:
-
EPS:
-$0.3009
Net Cash Flow:
-$11.29M
1W Performance:
-13.71%
1M Performance:
-15.33%
6M Performance:
+0.52%
1Y Performance:
-13.71%
1-Day Range:
$0.77$1.01
1-Week Range:
$0.77$1.17
52-Week Range:
$0.6866$1.57
Talphera Inc Stock (TLPH) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS